Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
- PMID: 20332255
- PMCID: PMC2857993
- DOI: 10.1158/1055-9965.EPI-09-1121
Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Abstract
Molecular epidemiologic studies of vitamin D and risk of cancer and other health outcomes usually involve a single measurement of the biomarker 25-hydroxyvitamin D [25(OH)D] in serum or plasma. However, the extent to which 25(OH)D concentration at a single time point is representative of an individual's long-term vitamin D status is unclear. To address this question, we evaluated within-person variability in 25(OH)D concentrations across serum samples collected at three time points over a 5-year period among 29 participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Blood collection took place year-round, although samples for a given participant were collected in the same month each year. The within-person coefficient of variation and intraclass correlation coefficient were calculated using variance components estimated from random effects models. Spearman rank correlation coefficients were calculated to evaluate agreement between measurements at different collection times (baseline, +1 year, +5 years). The within-subject coefficient of variation was 14.9% [95% confidence interval (CI), 12.4-18.1%] and the intraclass correlation coefficient was 0.71 (95% CI, 0.63-0.88). Spearman rank correlation coefficients comparing baseline to +1 year, +1 year to +5 years, and baseline to +5 years were 0.65 (95% CI, 0.37-0.82), 0.61 (0.29-0.81), and 0.53 (0.17-0.77), respectively. Slightly stronger correlations were observed after restricting to non-Hispanic Caucasian subjects. These findings suggest that serum 25(OH)D concentration at a single time point may be a useful biomarker of long-term vitamin D status in population-based studies of various diseases.
Figures
Similar articles
-
Vitamin D binding protein genetic isoforms, serum vitamin D, and cancer risk in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.PLoS One. 2024 Dec 20;19(12):e0315252. doi: 10.1371/journal.pone.0315252. eCollection 2024. PLoS One. 2024. PMID: 39705237 Free PMC article.
-
Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.BMJ. 2017 Oct 31;359:j4761. doi: 10.1136/bmj.j4761. BMJ. 2017. PMID: 29089348 Free PMC article.
-
Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.Int J Cancer. 2015 Mar 15;136(6):E654-64. doi: 10.1002/ijc.29157. Epub 2014 Sep 2. Int J Cancer. 2015. PMID: 25156182 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma.Int J Cancer. 2011 Mar 15;128(6):1414-24. doi: 10.1002/ijc.25439. Int J Cancer. 2011. PMID: 20473927
Cited by
-
Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial.Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1484-93. doi: 10.1158/1055-9965.EPI-13-1340. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 25085836 Free PMC article. Clinical Trial.
-
Associations of 25-hydroxyvitamin D2 and D3 with cardiovascular risk factors in childhood: cross-sectional findings from the Avon Longitudinal Study of Parents and Children.J Clin Endocrinol Metab. 2012 May;97(5):1563-71. doi: 10.1210/jc.2011-2335. Epub 2012 Feb 16. J Clin Endocrinol Metab. 2012. PMID: 22344194 Free PMC article.
-
Pre-diagnostic circulating vitamin D and risk of melanoma in men.PLoS One. 2012;7(4):e35112. doi: 10.1371/journal.pone.0035112. Epub 2012 Apr 25. PLoS One. 2012. PMID: 22558121 Free PMC article.
-
Intraindividual variation in plasma 25-hydroxyvitamin D measures 5 years apart among postmenopausal women.Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):916-24. doi: 10.1158/1055-9965.EPI-12-0026. Epub 2012 Apr 20. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22523182 Free PMC article.
-
Vitamin D Status and Prevalent Early Age-Related Macular Degeneration in African Americans and Caucasians: The Atherosclerosis Risk in Communities (ARIC) Study.J Nutr Health Aging. 2017;21(7):772-780. doi: 10.1007/s12603-016-0827-6. J Nutr Health Aging. 2017. PMID: 28717807 Free PMC article.
References
-
- Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control. 2005;16:83–95. - PubMed
-
- Garland CF, Gorham ED, Mohr SB, Garland FC. Vitamin D for cancer prevention: global perspective. Ann Epidemiol. 2009;19:468–83. - PubMed
-
- Gorham ED, Garland CF, Garland FC, et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med. 2007;32:210–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical